哮喘与治疗：吸入性皮质类固醇、皮质类固醇性骨质疏松症与慢性哮喘骨折风险。
Asthma and therapeutics: inhaled corticosteroids, corticosteroid osteoporosis, and the risk of fracture in chronic asthma.
机构信息
Emeritus Professor of Medicine, University of Western Ontario, Division of Clinical Immunology and Allergy, Department of Medicine, London Health Sciences Centre, London, Ontario.
出版信息
Allergy Asthma Clin Immunol. 2005 Mar 15;1(1):28-33. doi: 10.1186/1710-1492-1-1-28.
Current guidelines for the diagnosis and treatment of osteoporosis do not address the risks to bone density and the likelihood of fracture that may be associated with inhaled corticosteroid treatment for asthma. This review outlines an approach to the use of bone densitometry in clinical practice for the diagnosis, prevention, and treatment of osteoporosis in asthmatic patients receiving inhaled corticosteroid therapy.
目前的骨质疏松症诊断和治疗指南并未涉及吸入性皮质类固醇治疗哮喘可能带来的骨密度风险和骨折可能性。本文综述了一种在临床实践中使用骨密度仪的方法，用于诊断、预防和治疗接受吸入性皮质类固醇治疗的哮喘患者的骨质疏松症。
Zotero 插件